TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | -12 | -32 | -31 | -55 | 0 | -33 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/21/16 16:36 | 6/17/16 | JUNO | Juno Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Levitsky Hyam | WA | O | EVP,Rese | S | -531 | 42.77 | 33 | -12 | -10 | 117 | D | -15 | -3 | 11 | 13 | 0 | -5 | 1 | 0 | -12 | -32 | -31 | -55 | ||
3/3/09 11:28 | 2/27/09 | AGEN | Antigenics Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Levitsky Hyam | NY | D | M.d | 0 | 0.00 | 0 | 15 | New | 15 | 6 | 6 | 58 | 187 | 590 | 148 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |